Results 111 to 120 of about 2,141 (187)

JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study. [PDF]

Dermatol Ther (Heidelb)
Facheris P, Gargiulo L, Ibba L, Valenti M, D'Oria F, Foggi G, Falcidia C, Di Giulio S, Vignoli CA, Costanzo A, Narcisi A.   +10 more
europepmc   +1 more source

Dose Adjustment of JAK Inhibitors for the Management of Moderate-to-Severe Atopic Dermatitis: A Single-Centre Retrospective Study. [PDF]

Medicina (Kaunas)
Falcidia C, D'Oria F, Foggi G, Facheris P, Bianco M, Ibba L, Narcisi A, Costanzo A, Gargiulo L.   +8 more
europepmc   +1 more source

Intentional overdose of abrocitinib in an adolescent

JAAD Case Reports
Kathy T. LeSaint, MD, Kayla J. Kendric, MD   +1 more
openaire   +3 more sources

Refractory nail lichen planus treated successfully with the Janus kinase 1 inhibitor abrocitinib: A case report. [PDF]

J Int Med Res
Wang L, Lei X, Li L, Cheng Q.
europepmc   +1 more source

Pseudorheumatoid nodules treated with abrocitinib

JAAD Case Reports
Bizimungu, Samantha, Safoine, Meryem, Watters, Kevin, Lemieux, Alexandre   +3 more
openaire   +3 more sources

Long-term efficacy of abrocitinib in patients with moderate-to-severe atopic dermatitis to 2 years. [PDF]

J Eur Acad Dermatol Venereol
Gooderham MJ, Silverberg JI, De Bruin-Weller M, Kircik L, Thaçi D, Zhao Z, Valenzuela F, Nomura T, Selfridge A, Fan D, Myers DE, Biswas P, Farooqui SA, Watkins M, Koppensteiner H.   +14 more
europepmc   +1 more source

Use of abrocitinib in severe atopic dermatitis. [PDF]

Rev Assoc Med Bras (1992)
Cruz MFMND, Criado GJ, Ortrolani TA, Martins MDS, Dinato SLME, Silvinato A, Bernardo WM.   +6 more
europepmc   +1 more source

Itch Relief and Quality-of-Life Improvement with Abrocitinib and Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE COMPARE and JADE DARE. [PDF]

Am J Clin Dermatol
Yosipovitch G, Gooderham MJ, Elmariah SB, Bonfanti G, Edwards RA, Gregoriou S, Biswas P, Myers DE, Alderfer J, Güler E, Koulias C.   +10 more
europepmc   +1 more source

Clinical Outcomes of Abrocitinib in Prurigo Spectrum Disorders: A Case Series. [PDF]

Cureus
Chakravadhanula U, Nagarajan M, Bhat S.
europepmc   +1 more source

Successful Treatment of Pigmented Purpuric Dermatoses With Abrocitinib: A Case Report. [PDF]

Clin Case Rep
Zhang Y, Lu X, Li C.
europepmc   +1 more source